HLA class II expression in human tumor lines

被引：10

作者：

Blanck, G ^{[1
]}

机构：

[1] Univ S Florida, H Lee Moffitt Canc Ctr, Program Immunol, Coll Med,Dept Biochem & Mol Biol, Tampa, FL 33612 USA

来源：

MICROBES AND INFECTION | 1999年 / 1卷 / 11期

关键词：

D O I：

10.1016/S1286-4579(99)00226-9

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：913 / 918

页数：6

共 28 条

[1] The retinoblastoma protein pathway in cell cycle control and cancer [J].

Bartek, J ;

Bartkova, J ;

Lukas, J .

EXPERIMENTAL CELL RESEARCH, 1997, 237 (01) :1-6

[2]

Baskar S, 1996, J IMMUNOL, V156, P3821

[3] MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II(+)B7-1(+) TUMOR-CELLS ARE POTENT VACCINES FOR STIMULATING TUMOR REJECTION IN TUMOR-BEARING MICE [J].

BASKAR, S ;

GLIMCHER, L ;

NABAVI, N ;

JONES, RT ;

OSTRANDROSENBERG, S .

JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :619-629

[4] Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs [J].

Chen, PL ;

Riley, DJ ;

Chen, YM ;

Lee, WH .

GENES & DEVELOPMENT, 1996, 10 (21) :2794-2804

[5] The regulation of E2F by pRB-family proteins [J].

Dyson, N .

GENES & DEVELOPMENT, 1998, 12 (15) :2245-2262

[6] Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4(+) anti-tumor T cells requires tumor expression of cell surface MHC class II molecules [J].

Frey, AB ;

Cestari, S .

CELLULAR IMMUNOLOGY, 1997, 178 (01) :79-90

[7]

Huettner C, 1997, ANTICANCER RES, V17, P3217

[8]

KARA CJ, 1993, J IMMUNOL, V150, P4934

[9]

Lamphear JG, 1998, J IMMUNOL, V160, P615

[10] IFN-gamma inducibility of class II transactivator is specifically lacking in human tumour lines: Relevance to retinoblastoma protein rescue of IFN-gamma inducibility of the HLA class II genes [J].

Lu, Y ;

Tschickardt, ME ;

Schmidt, BJ ;

Blanck, G .

IMMUNOLOGY AND CELL BIOLOGY, 1997, 75 (04) :325-332

← 1 2 3 →